Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma

ORL

Volumn 71, Issue 5, 2009, Pages 251-256

  Lyford Pike, Sofia ^a   Ha, Patrick K ^a,b   Jacene, Heather A ^a   Saunders, John R ^a,b   Tufano, Ralph P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

Advanced head and neck squamous cell carcinoma; Neck dissection; Primary chemoradiation

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; TREATMENT OUTCOME;

EID: 70349252255     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000237737     Document Type: Article

References (33)

1. Taylor SG 4th, Murthy AK, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385-395.
2. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-2086.
3. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage II and IV squamous cell head and neck cancer: Preliminary results. Head Neck 1997; 19: 567-575. (Pubitemid 27407310)
4. Kutler DI, Patel SG, Shah JP: The role of neck dissection following definitive chemoradiation. Oncology 2004; 18: 993-998.
5. Stensen KM, Haraf DJ, Pelzer H, et al: The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. Arch Otol Head Neck Surg 2000; 126: 950-956.
6. Brizel DM, Prosnitz RG, Hunter S, et al: Necessity for adjuvant neck dissection in the setting of concurrent chemoradiation for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1418-1423.
7. McHamm SA, Adelstein DJ, Rybicki LA, et al: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003; 25: 791-798.
8. Frank DK, Hu KS, Culliney BE, et al: Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 205; 115: 1015-1020.
9. Argiris A, Stenson KM, Brockstein BE, et al: Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004; 26: 447-455.
10. Lavertu P, Aldelstein DJ, Saxton JP, et al: Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997; 19: 559-566. (Pubitemid 27407309)
11. Pelliteri PK, Ferlito A, Rinaldo A, et al: Planned neck dissection following advanced chemoradiotherapy for advanced head and neck cancer: Is it necessary for all? (clinical review). Head Neck 2006; 28: 166-175.
12. Armstrong J, Pfister D, Strong E, et al: The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1993; 26: 759-765.
13. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB: Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999; 125: 401-405.
14. Lavertu P, Bonafide JP, Adelstein DJ, et al: Comparison of surgical complications after organ preservation therapy in patients with stage III and IV squamous cell head and neck cancer. Arch Otolaryngol Head and Neck Surg 1998; 124: 401-406.
15. Velazquez RA, McGuff HS, Sycamore D, Miller FR: The role of computed tomographic scans in the management of N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004; 130: 74-77.
16. Giron J, Chisin R, Paul JL, et al: Multimodality imaging of cervical adenopathies. Eur J Radiol 1996; 21: 159-166.
17. Anzai Y, Brunberg JA, Lufkin RB: Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 1997; 7: 774-783.
18. Gussack GS, Hudgin PA: Imaging modalities in recurrent head and neck tumors. Laryngoscope 1991; 101: 119-124.
19. Kubota K, Yokoyama J, Yamaguchi K, et al: FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radiochemotherapy: Comparison with MRI/ CT. Eur J Nucl Med Mol Imaging 2004; 31: 590-595.
20. Brkovich VS, Miller FR, Karnad AB, Hussey DG, McGuff HS, Otto RA: The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006; 116: 855-858.
21. Fakhry N, Lussato D, Jacob T, Giorgi R, Giovanni A, Zanaret M: Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications. Eur Arch Otorhinolaryngol 2007; 264: 531-538.
22. Branstetter BF 4th, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, Meltzer CC: Head and neck malignancy: Is PET/CT more accurate than PET or CT alone? Radiology 2005; 235: 580-586.
23. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM: Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004; 231: 65-72.
24. Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R: PET/CT vs. contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck 2006; 28: 487-495.
25. Gourin CG, Williams HT, Seabolt WN, Herdman AV, Howington JW, Terris DJ: Utility of positron emission tomographycomputed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 2006; 116: 705-710.
26. Ong SC, Schröder H, Lee NY, et al: Clinical utility of 18 F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008; 49: 532-540.
27. Nayak JV, et al: Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: The utility of PETCT. Laryngoscope 2007; 117: 2129-2134.
28. Westra WH, Forastiere AA, Eisele DW, Lee DJ: Squamous cell granulomas of the neck: histologic regression of metastatic squamous cell carcinoma following chemotherapy and/ or radiotherapy. Head Neck 1998; 20: 515-521.
29. Strasser MD, Gleich LL, Miller MA, Saavedra HI, Gluckman JL: Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 1999; 109: 1776-1780.
30. Greven KM, Williams DW III, Keyes JW Jr, et al: Positron emission tomography of patients with head and neck carcinoma before and after high-dose irradiation. Cancer 1994; 74: 1355-1359.
31. Porceddu SV, Jarmolowski E, Hicks RJ, et al: Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer. Head Neck 2005; 27: 175-181.
32. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S: Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000; 110: 1493-1500.
33. Greven KM, Williams DW III, McGuirt WF Sr, et al: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001; 23: 942-946.